Login

T2 Biosystems: Going, Going, Gone?

Trading Alert: The stock of T2 Biosystems is up 10% in early trading on positive comments from management and analysts

T2 Biosystems (TTOO) is up some 10% in early trading today on a confluence of positive news. The company reported slightly better than expected first quarter results with revenues and its…

This could be a game changer both the company and the detection of sepsis. T2 Biosytems’ platform using this panel can detect sepsis caused by candida in under 5 hours compared to the current average of almost five days using current standard procedures. Sepsis is one of the leading causes of death in the United States. Its mortality rate can reach 30% and affecting primarily elderly, immunocompromised, and critical care patients. The cost of treating sepsis amounted to over $23 billion in 2013, or 5% of costs related to domestic hospital stays. Candida is the deadliest form of common bloodstream infections that cause sepsis (mortality rate on average 40%) and affects over 135,000 patients in the United States each year. A study published in the American Journal of Respiratory and Critical Care Medicine concluded that targeted antifungal treatment provided within 24 hours of symptoms appearing led to hospital stays decreasing by ten days and average cost of care per patient decreasing by $30,000.

Stories

Fresh Conversations